To determine whether the upregulation of glycolytic and non-canonical TCA cycle gene expression observed in the Kras mutant mouse model is conserved in human cancer, we performed a detailed analysis of a scRNA-seq dataset comparing AMs from 12 NSCLC patient tumor samples to those from normal lung tissue (24, 25). This evidence concerns the gene KRAS and cancer.